XML 8 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 26,305 $ 50,193
Marketable securities 230,727 285,884
Trade accounts receivable, net of allowance for credit losses of $21,450 as of June 30, 2026, and $21,411 as of December 31, 2025 64,938 84,762
Prepaid income taxes 110,569 107,099
Other current assets 22,231 22,552
Total current assets 454,770 550,490
Marketable securities, long-term 294,316 369,269
Fixed assets, net 113,068 112,549
In-process research & development 68,490 68,490
Other intangible assets, net 80,769 64,791
Goodwill 53,861 25,080
Other long-term assets 23,949 22,856
Total assets 1,089,223 1,213,525
Current liabilities    
Accounts payable 15,555 18,654
Accrued liabilities 23,507 34,057
Customer deposit 28,808 28,145
Contract liabilities 3,404 3,635
Notes payable, current 482 476
Total current liabilities 71,756 84,967
Deferred tax liabilities 6,892 6,936
Unrecognized tax benefits 5,617 7,283
Other long-term liabilities 8,972 7,624
Total liabilities 93,237 106,810
Commitments and Contingencies (Note 8)
Stockholders’ equity    
Common stock, $0.0001 par value per share, 50,000 shares authorized, 35,057 shares issued and 27,515 shares outstanding as of June 30, 2026, and 34,501 shares issued and 31,081 shares outstanding as of December 31, 2025 4 3
Preferred stock, $0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding as of June 30, 2026, and December 31, 2025
Additional paid-in capital 524,097 574,520
Accumulated other comprehensive income 1,920 7,512
Retained earnings 475,598 529,954
Total Fulgent stockholders' equity 1,001,619 1,111,989
Noncontrolling interest (5,633) (5,274)
Total stockholders’ equity 995,986 1,106,715
Total liabilities and stockholders’ equity $ 1,089,223 $ 1,213,525